1 Abo und 0 Abonnenten

MedMen on Its Last Legs with Disappointing Q2 Results

MedMen (CNSX: MMEN) is cutting costs, but is it enough to stave off bankruptcy now, or in two years? #stocks #marijuanastocks



Read the full article